BiotechTube
Home/MAIA Biotechnology/Jeffrey C. Himmelreich
JC

Jeffrey C. Himmelreich

Head of Finance

MAIA Biotechnology

Therapeutic Areas

Oncology

MAIA Biotechnology Pipeline

DrugIndicationPhase
Ateganosine (THIO)CancerPhase 2
Second-generation telomere targeting agentsCancerPre-clinical/Research

Leadership Team at MAIA Biotechnology

VV
Vlad Vitoc
Chief Executive Officer and Chairman
SM
Sergei M. Gryaznov
Chief Scientific Officer
View full MAIA Biotechnology profile